Logo image of EFX

EQUIFAX INC (EFX) Stock Analyst Ratings

NYSE:EFX - New York Stock Exchange, Inc. - US2944291051 - Common Stock - Currency: USD

271.5  -0.42 (-0.15%)

After market: 271.5 0 (0%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to EFX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 293.67. This target is 8.16% above the current price.
EFX was analyzed by 27 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about EFX.
In the previous month the buy percentage consensus was at a similar level.
EFX was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
EFX Historical Analyst RatingsEFX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 271.50257.55300.39293.67325.50 - -5.14% 10.64% 8.16% 19.89%
EFX Current Analyst RatingEFX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-06-10 Morgan Stanley Maintains Overweight -> Overweight
2025-05-22 Oppenheimer Maintains Outperform -> Outperform
2025-05-21 Wells Fargo Maintains Overweight -> Overweight
2025-04-23 Needham Reiterate Buy -> Buy
2025-04-23 RBC Capital Reiterate Outperform -> Outperform
2025-04-14 Wells Fargo Maintains Overweight -> Overweight
2025-04-04 Barclays Downgrade Overweight -> Equal-Weight
2025-02-07 UBS Maintains Buy -> Buy
2025-02-07 Needham Maintains Buy -> Buy
2025-02-07 Oppenheimer Maintains Outperform -> Outperform
2025-02-07 Stifel Maintains Buy -> Buy
2025-02-07 Barclays Maintains Overweight -> Overweight
2025-02-03 Wells Fargo Maintains Overweight -> Overweight
2025-01-28 Morgan Stanley Maintains Overweight -> Overweight
2025-01-15 Jefferies Maintains Buy -> Buy
2025-01-10 Wells Fargo Maintains Overweight -> Overweight
2024-12-16 Exane BNP Paribas Upgrade Neutral -> Outperform
2024-12-12 Wolfe Research Downgrade Outperform -> Peer Perform
2024-12-12 Morgan Stanley Upgrade Equal-Weight -> Overweight
2024-11-20 Stifel Maintains Buy -> Buy
2024-11-19 Oppenheimer Maintains Outperform -> Outperform
2024-11-19 JP Morgan Maintains Overweight -> Overweight
2024-10-28 Needham Reiterate Buy -> Buy
2024-10-18 Needham Reiterate Buy -> Buy
2024-10-18 Wells Fargo Maintains Overweight -> Overweight
2024-10-18 JP Morgan Maintains Overweight -> Overweight
2024-10-18 Baird Maintains Outperform -> Outperform
2024-10-08 Oppenheimer Maintains Outperform -> Outperform
2024-10-02 Wells Fargo Maintains Overweight -> Overweight
2024-10-01 UBS Initiate Buy